Ars Pharmaceuticals Inc logo

Ars Pharmaceuticals Inc (SPRY)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
7. 00
-0.46
-6.1662%
$
755.7M Market Cap
- P/E Ratio
- Div Yield
2.13M Volume
-0.61 Eps
$ 7.46
Previous Close
Add Transaction
Day Range
6.92 7.3
Year Range
6.66 18.63
Want to track SPRY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
12 May 2026
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
19 Mar 2026
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
12 Nov 2025
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
6 Aug 2025
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
7 May 2025
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
19 Mar 2025
-
0.51
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
7 Nov 2024
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
8 Aug 2024
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
20 Jun 2024
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
9 May 2024
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
21 Mar 2024
-
-
Ars Pharmaceuticals Inc logo
SPRY Ars Pharmaceuticals Inc
31 Oct 2023
-
-

SPRY Earnings Reports FAQ

What is the earnings per share (EPS) for SPRY?

The current EPS is -0.61.

What is the company's earnings growth rate?

Ars Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Ars Pharmaceuticals Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Ars Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for SPRY at this time, as Ars Pharmaceuticals Inc has no recent EPS data to calculate it.